Literature DB >> 8228623

Lipopolysaccharide structure-function relationship in activation versus reprogramming of mouse peritoneal macrophages.

X Zhang1, D C Morrison.   

Abstract

Lipopolysaccharide (LPS) is one of the most potent stimuli for macrophages. The activities of LPS have been attributed to the lipid A region of the molecule. We have previously shown that pretreatment of macrophages with very low doses of LPS can selectively "reprogram" these cells to respond differentially to subsequent activation, as assessed by tumor necrosis factor-alpha and nitric oxide (NO) production. Here we demonstrate that the relative capacity of various LPS preparations for induction of down-regulation of subsequent LPS-activated NO production correlates well with their relative potency for initiation of NO formation. Although LPS-dependent activation can be regulated by pertussis toxin (PT)-sensitive factor, the LPS pretreatment-induced reprogramming is shown here to be refractory to regulation by PT. These results suggest that, although the structural components of LPS dictating the relative activities of the molecule for activation versus reprogramming are similar, there may exist different pathways in initiation of LPS-induced activation versus reprogramming.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8228623     DOI: 10.1002/jlb.54.5.444

Source DB:  PubMed          Journal:  J Leukoc Biol        ISSN: 0741-5400            Impact factor:   4.962


  18 in total

Review 1.  Immune therapy in sepsis: Are we ready to try again?

Authors:  Roger Davies; Kieran O'Dea; Anthony Gordon
Journal:  J Intensive Care Soc       Date:  2018-04-04

2.  Immunoregulatory potential of exopolysaccharide from Lactobacillus rhamnosus KL37: effects on the production of inflammatory mediators by mouse macrophages.

Authors:  Marta Ciszek-Lenda; Bernadeta Nowak; Małgorzata Sróttek; Andrzej Gamian; Janusz Marcinkiewicz
Journal:  Int J Exp Pathol       Date:  2011-09-22       Impact factor: 1.925

3.  Dissociation of endotoxin tolerance and differentiation of alternatively activated macrophages.

Authors:  Rajesh Rajaiah; Darren J Perkins; Swamy Kumar Polumuri; Aiping Zhao; Achsah D Keegan; Stefanie N Vogel
Journal:  J Immunol       Date:  2013-03-29       Impact factor: 5.422

4.  Low-dose lipopolysaccharide (LPS) pretreatment of mouse macrophages modulates LPS-dependent interleukin-6 production in vitro.

Authors:  N Hirohashi; D C Morrison
Journal:  Infect Immun       Date:  1996-03       Impact factor: 3.441

Review 5.  Sepsis-induced immunosuppression: from cellular dysfunctions to immunotherapy.

Authors:  Richard S Hotchkiss; Guillaume Monneret; Didier Payen
Journal:  Nat Rev Immunol       Date:  2013-11-15       Impact factor: 53.106

6.  SP-D-dependent regulation of NO metabolism in lipopolysaccharide-stimulated peritoneal macrophages.

Authors:  E N Atochina-Vasserman; E V Abramova; Y Tomer; P Scott; V A Nazarov; S V Kruglov; M F Beers; A J Gow; I Yu Malyshev
Journal:  Bull Exp Biol Med       Date:  2009-04       Impact factor: 0.804

Review 7.  Monitoring immune dysfunctions in the septic patient: a new skin for the old ceremony.

Authors:  Guillaume Monneret; Fabienne Venet; Alexandre Pachot; Alain Lepape
Journal:  Mol Med       Date:  2008 Jan-Feb       Impact factor: 6.354

8.  Regulation of an essential innate immune response by the p50 subunit of NF-kappaB.

Authors:  J Bohuslav; V V Kravchenko; G C Parry; J H Erlich; S Gerondakis; N Mackman; R J Ulevitch
Journal:  J Clin Invest       Date:  1998-11-01       Impact factor: 14.808

9.  Mechanisms involved in the pathogenesis of sepsis are not necessarily reflected by in vitro cell activation studies.

Authors:  C R Amura; R Silverstein; D C Morrison
Journal:  Infect Immun       Date:  1998-11       Impact factor: 3.441

10.  Molecular mechanism responsible for the priming of macrophage activation.

Authors:  Hui Deng; Urmila Maitra; Matt Morris; Liwu Li
Journal:  J Biol Chem       Date:  2012-12-21       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.